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Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment 
of the requirements for the degree of Master of Science 
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Three Newcastle disease virus (NDV) isolates namely; F, Ijuk and OllC were tested 
for their anticancer properties against two breast cancer cell lines, M CF -7 and 
MDA-MB-231 .  Each virus strain was propagated in 1 0-day old embryonated eggs. 
Purification was carried out by density gradient centrifugation using sucrose. The 
titer of each virus strain was determined by hemagglutination (HA) test. Screening 
of NDV strains for anticancer properties on breast cancer cells was performed by a 
colorimetric cytotoxic assay using tetrazolium salt (MTT). F strain displayed 
cytotoxic activity on both breast cancer cells with an IC50 value of 8 HAU for 
MDA-MB-231 cells and 2048 HAU for MCF-7 cells. Meanwhile Ijuk showed 
cytotoxic activity against MDA-MB-231 cells only with an IC50 value of 8.6 HAD. 
Strain OllC did not exhibit any cytotoxic activity towards both breast cancer cells. 
Inactivation of the virus at 1 00°C for 30 minutes destroyed its ability to kill the 
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breast cancer cells. Positive control experiment involved treatment of the cells with 
tamoxifen, an estrogenic antagonist agent. Negative control experiment was carried 
out by infecting the virus onto normal mouse fibroblasts (3T3 cell). No cytotoxic 
activity was observed on 3T3 cells following infection at low virus titer. However, 
infection at higher virus titer resulted in 50% inhibition of cell growth. Infection of 
the virus displayed clear evidence of apoptosis which was detected as a ladder-like 
pattern on agarose gel electrophoresis. This was further confirmed by TEM which 
provided ultrastructural changes of the infected cells. The role of sialic acid receptor 
was also studied based on neuraminidase (NA) and sialyllactose (SLL) treatment. 
Treatment of the cells with NA did not destroy the ability of the virus to cause 
apoptosis. Meanwhile a reduction in the ability of the virus to cause apoptosis was 
observed in the treatment of SLL. However there was no significant difference 
between the SLL-treated virus (27.05%) and untreated virus (30.87%). Based on the 
results obtained, this study showed that NDV strains, F and ljuk have the potential 
to be developed as an anticancer agent. Mechanisms by which the virus infects and 
kills the cells need further studies. The role of sialic acid receptors in NDV -induced 
oncolytic effects requires further studies. 
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Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
KESAN VIRUS PENYAKIT NEWCASTLE (NDV) KE ATAS SEL KANSER 
PAYUDARA 
Oleh 
HARYATI SHILA MOHAMAD WALl 
Ogos 2003 
Pengerusi: Profesor Aini bt. Ideris, PhD 
Fakulti : Perubatan Veterinar 
Tiga isolat virus penyakit Newcastle (NDV) iaitu; F, ljuk dan O l lC telah diuji bagi 
kesan anti kanser terhadap dua jenis sel kanser payudara, MCF-7 dan MDA-MB-
231. Setiap strain virus dibiakkan dalam telur berembrio berusia 10 hari. Penulenan 
virus dijalankan melalui kaedah pengemparan gradien berasaskan ketumpatan 
menggunakan sukrosa. Titratan virus tersebut ditentukan melalui ujian 
hemaglutinasi (HA). Proses penyaringan strain NDV bagi ciri-ciri antikanser ke atas 
sel kanser payudara melibatkan esei sitotoksik berasaskan warna menggunakan 
garam tetrazolium (MTT). Strain F mempamerkan aktiviti sitotoksik ke atas kedua-
dua jenis sel kanser payudara dengan nilai IC50 bersamaan 8 HAU bagi sel-sel 
MDA-MB-231 dan 2048 HAU bagi sel-sel MCF-7. Manakala ljuk menunjukkan 
aktiviti sitotoksik hanya pada sel-sel MDA-MB-231 sahaja dengan nilai IC50 
sebanyak 8.6 HAU. Strain O l lC tidak menunjukkan sebarang aktiviti sitotoksik 
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terhadap kedua-dua jenis sel kanser payudara. Penyahaktifan virus tersebut pada 
100°C selama 30 minit memusnahkan keupayaannya untuk membunuh sel-sel 
kanser payudara. Ujikaji kawalan positif melibatkan rawatan sel tersebut dengan 
tamoxifen, sejenis agen antagonis estrogen. Ujikaji kawalan negatif dijalankan 
melalui jangkitan virus pada sel fibroblast tikus normal (sel 3T3). Tiada aktiviti 
sitotoksik diperhatikan pada sel 3T3 tersebut pada titratan virus yang rendah. Walau 
bagaimanapun, jangkitan pada titratan virus yang tinggi menyebabkan perencatan 
pertumbuhan sel sebanyak 50%. Jangkitan oleh virus menunjukkan bukti jelas 
berlakunya apoptosis yang dikenalpasti melalui corak tangga pada elektroforesis gel 
agar. Keadaan ini disahkan melalui TEM yang menunjukkan perubahan 
ultrastruktur pada sel-sel yang dijangkiti. Kajian ke atas peranan penerima sialic 
asid dijalankan menerusi rawatan neuraminides (NA) dan sialilaktosa (SLL). 
Rawatan NA ke atas sel-sel tersebut tidak memusnahkan keupayaan virus tersebut 
untuk menyebabkan apoptosis. Manakala penurunan keupayaan Virus dalam 
menyebabkan apoptosis diperhatikan pada rawatan menggunakan SLL. Walau 
bagaimanapun tiada perbezaan ketara diperhatikan antara virus yang telah dirawat 
dengan SLL (27.05%) dan virus tanpa rawatan (30.87%). Berdasarkan keputusan 
yang didapati dalam kajian ini, strain NDV, F dan Ijuk mempunyai potensi untuk 
dibangunkan sebagai agen antikanser. Mekanisme bagaimana virus tersebut 
menjangkiti dan membunuh sel masih perlu kajian lanjutan. Kajian berkenaan 
peranan penerima asid sialik di dalam kesan onkolitik yang diakibatkan oleh NDV 
memerlukan kajian lanjut. 
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CHAPTER I 
GENERAL INTRODUCTION 
Cancer is a much feared word when it comes to our health. Cancer is a general name 
given to a group of about 2 1 0  diseases and it can affect any organ of the body. 
Cancerous cells behave abnormally where they keep on dividing and forming more 
cells without control or order (Brock, 1993). These cells will form a mass of extra 
tissue called growth or tumor. In general, a tumor can be either benign or malignant. 
Both types differ in their ability to spread to other parts of  the body. Benign tumors 
are not cancerous and can be removed where usually they do not come back. 
Furthermore benign tumors do not spread to invade other parts of the body. On the 
other hand, malignant tumors are cancerous and can spread or metastasize and 
damage nearby tissues and organs. Cancer cells can also break away from the initial 
mass and enter the bloodstream or lymphatic system thus forming new tumors in 
other parts of the body. Cancer cells differ in very minute ways from a normal cell 
that the immune system is able to tolerate it rather than attacking it. 
Breast cancer is the common malignancy affecting women worldwide. It happens 
when cells in the breast begin to grow out of control and invade nearby tissues or 
spread throughout the body. Breast cancer can metastasize and spread to the lymph 
glands and other parts of the body. The most common type of breast cancer is ductal 
carcinoma, which begins in the cells of the ducts. Among the risk factors 
responsible for breast cancer are age, a family history of breast cancer, previous 
history of breast cancer, never having given birth and menstruating at an early age. 
Standard treatments commonly used for this type of cancer are surgery, radiation 
therapy, chemotherapy and hormone therapy (Aikin, 1 996). 
Since the past century, novel approaches for the treatment of cancer have been 
developed. Besides conventional method such as surgery, radiotherapy and 
chemotherapy, immunotherapy with virus have received adequate attention as 
cancer treatment (Horvath et al., 1999). This type of treatment is also known as 
complementary and alternative medicine (CAM). Therapies are being developed 
focusing on how the body fights cancer on its own. Although it is still experimental, 
cancer vaccines are gaining interest as a method of cancer treatment. However, this 
type of treatment is therapeutic which stresses on treating the cancer rather than 
preventing it. The main role of cancer vaccines is preventing cancer from recurring 
after the elimination of primary tumor via surgery, radiation or chemotherapy. 
Cancer vaccines initiate the immune system to attack existing cancerous cells. S ince 
fighting established cancers are quite a task, cancer vaccines are usually used in 
combination with additional substances such as cytokines or adjuvants to help 
stimulate the immune system. Besides trying to provoke an immune response, 
cancer vaccines must also be able to stimulate the immune system to overcome 
tolerance against the cancerous cells. A cancer vaccine can be made either of whole 
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tumor cells or antigens. The antigens could comprise of proteins, genetic material 
(RNA or DNA), antibodies or viruses. 
Over 30 viruses have been tested in various cancers including Newcastle disease 
virus (NDV), herpes simplex virus (HSV), mumps, measles and influenza. Although 
genetically engineered viruses are being tested for this matter, some naturally 
occurring viruses were shown to possess oncolytic activity. Observations in early 
1920s indicated that certain viruses replicated in and lysed murine and other 
experimental tumors. Human cervical carcinoma regressed following inoculation of 
the patient with attenuated rabies vaccine (De Pace, 1912). Remissions of Burkitt's 
and Hodgkin's lymphomas following natural infection with measles virus were also 
reported (B luming and Ziegler, 1971). The contribution of the virus to tumor 
regression is possibly mediated by the virus stimulating an anti-tumor immune 
response rather than infecting and destroying the tumor directly (Ring, 2002). Some 
naturally occurring viruses of veterinary importance have been adapted by serial 
passage in tumor cells to increase their oncolytic efficacy (Hammon et aI., 1963; 
Y ohn et aI., 1968). NOV strains adapted to Ehrlich ascites carcinoma cells (Cassel 
et aI., 1983) or human melanoma cells (Ahlert and Schirrmacher, 1990) possess this 
trait. 
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Newcastle disease virus (NDV) or avian paramyxovirus 1 is a renowned pathogen 
of fowl. It contributes to substantial loss to the poultry industry economically. The 
virus is transmitted via ingestion or inhalation depending on its pathotypes. Despite 
recent advances in the control of disease by vaccination and mass slaughtering, 
outbreaks still occur occasionally as was the case in Australia (Westbury, 2001)  and 
Malaysia (Yusoff, 2001). Despite being a threat to the poultry industry, NDV has 
been exploited as a potential treatment of cancer. It has been shown to display a 
distinguished ability as an oncolytic agent (Sinkovics et al., 2000a). Immunisation 
with autologous (or allogeneic) NDV 73T strain post-surgically prevents relapses of 
malignant melanoma in human (Cassel and Murray, 1992). Other study shows that 
NDV has been successfully used to prevent relapses of surgically removed kidney 
carcinoma (Kirchner et. aI., 1 995). Among other cancer type that shows relapses 
following NDV treatment are Daudi Burkitt's lymphoma cells, neuroblastoma, 
fibrosarcoma, melanoma, colon and kidney carcinoma. Naturally occurring viruses 
showing potential as an oncolytic agent must be amenable to genetic manipulation. 
It should be well characterised in terms of replication in different cell types and 
pathogenesis in human popUlation. Studies indicate that while NDV replicates and 
kills cancer cells selectively, it does not affect normal cells (Reichard et al., 1 992). 
Furthermore, NDV has the advantage of relative safety and will only cause mild 
conjunctivitis and laryngitis in human, in some cases. Low-grade fever was also 
observed in clinical trials using low dose ofNDV strain 73T (Cassel, 1 965). 
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In Malaysia, cancer is reported as the fifth major cause of deaths. A report by Majlis 
Kanser Nasional, Malaysia (MAKNA) stated that an estimation of about 40,000 
cases of cancer is diagnosed every year. The major cancers occurring in Malaysia 
are the cancer of lung, mouth, stomach, liver, breast and cervix. Breast cancer is the 
major cause of cancer deaths among Malaysian women. It is the most common 
cancer and the number one cause of cancer deaths amongst women in Malaysia. 
Screening for breast cancer involves mammograms, clinical breast examinations, 
and breast self-examinations. Conventional method of cancer treatment such as 
surgery, radiotherapy and chemotherapy also applies to breast cancer. This study 
was conducted to look into other possible methods in treating breast cancer. 
Newcastle disease was reported in Malaya as early as 1934 (reviewed by Yusoff and 
Ideris, 2003; reviewed by Aini, 1990). Recent outbreaks in Malaysia occurred in the 
year 2000 and 2001 which resulted in mass eradication of infected flocks. Several 
different strains of NDV have been isolated from these outbreaks. However, the 
oncolytic ability of local NDV strains is not known. Hence, a collaborative project 
between UPM, USM and MAKNA has been established in identifying local NDV 
with oncolytic properties on breast cancer cells. Furthermore, the oncolytic effects 
of NDV were tested against two types of breast cancer cell lines; estrogen receptor 
positive (ER+) and estrogen receptor negative (ER-). 
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The objectives of this study are therefore: 
i) To propagate and purify different NDV isolates. 
ii) To screen NDV strains with cytotoxic effects against breast cancer cell 
lines. 
iii) To detennine the cytolytic effects and the nature of cell death caused by 
NDV strains. 
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